Castle Biosciences

Castle Biosciences is a commercial-stage molecular diagnostics company that develops and delivers clinically actionable genomic tests. Its products support diagnosis, prognosis, and treatment decisions primarily in dermatologic cancers, uveal melanoma, Barrett’s esophagus, and related medical conditions.

Relationship details are part of the Pro plan.